HK1030157A1 - Use of consensus interferon and compositions comprising consensus interferon. - Google Patents
Use of consensus interferon and compositions comprising consensus interferon.Info
- Publication number
- HK1030157A1 HK1030157A1 HK01101141A HK01101141A HK1030157A1 HK 1030157 A1 HK1030157 A1 HK 1030157A1 HK 01101141 A HK01101141 A HK 01101141A HK 01101141 A HK01101141 A HK 01101141A HK 1030157 A1 HK1030157 A1 HK 1030157A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- consensus interferon
- compositions
- consensus
- interferon
- ifn
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/212—IFN-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/911,893 US6013253A (en) | 1997-08-15 | 1997-08-15 | Treatment of multiple sclerosis using consensus interferon and IL-1 receptor antagonist |
PCT/US1998/014622 WO1999008702A1 (en) | 1997-08-15 | 1998-07-15 | Methods for treatment of patients afflicted wih multiple sclerosis using consensus interferon |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1030157A1 true HK1030157A1 (en) | 2001-04-27 |
Family
ID=25431058
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK01101141A HK1030157A1 (en) | 1997-08-15 | 2001-02-16 | Use of consensus interferon and compositions comprising consensus interferon. |
Country Status (18)
Country | Link |
---|---|
US (1) | US6013253A (da) |
EP (1) | EP1003546B1 (da) |
JP (1) | JP3813440B2 (da) |
KR (1) | KR100415636B1 (da) |
CN (1) | CN1183963C (da) |
AT (1) | ATE338563T1 (da) |
AU (1) | AU741074B2 (da) |
CA (1) | CA2299361C (da) |
CY (1) | CY1107314T1 (da) |
DE (1) | DE69835823T2 (da) |
DK (1) | DK1003546T3 (da) |
ES (1) | ES2267188T3 (da) |
HK (1) | HK1030157A1 (da) |
HU (1) | HU229045B1 (da) |
IL (2) | IL134345A0 (da) |
PT (1) | PT1003546E (da) |
TW (1) | TW474817B (da) |
WO (1) | WO1999008702A1 (da) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030007972A1 (en) * | 1999-02-24 | 2003-01-09 | Edward Tobinick | Cytokine antagonists and other biologics for the treatment of bone metastases |
US7214658B2 (en) * | 2004-07-06 | 2007-05-08 | Tact Ip, Llc | Method of delivering a TNF antagonist to the brain of a human by perispinal administration without direct intrathecal injection |
US6471961B1 (en) * | 1999-02-24 | 2002-10-29 | Edward L. Tobinick | Interleukin antagonists for the treatment of neurological, retinal and muscular disorders |
US6982089B2 (en) | 1999-02-24 | 2006-01-03 | Tact Ip, Llc | Cytokine antagonists for neurological and neuropsychiatric disorders |
US6623736B2 (en) * | 2000-05-02 | 2003-09-23 | Edward L. Tobinick | Interleukin antagonists for the treatment of neurological, retinal and muscular disorders |
US20030027755A1 (en) * | 2000-12-08 | 2003-02-06 | Jian Guan | Compositions and methods for the rescue of white matter |
US7714020B2 (en) | 2001-05-24 | 2010-05-11 | Neuren Pharmaceuticals Limited | Treatment of non-convulsive seizures in brain injury using G-2-methyl-prolyl glutamate |
JP2004536069A (ja) | 2001-05-24 | 2004-12-02 | ニューロンズ・リミテッド | Gpe類縁体及びペプチドミメティック |
US7605177B2 (en) | 2001-05-24 | 2009-10-20 | Neuren Pharmaceuticals Limited | Effects of glycyl-2 methyl prolyl glutamate on neurodegeneration |
US7230167B2 (en) | 2001-08-31 | 2007-06-12 | Syngenta Participations Ag | Modified Cry3A toxins and nucleic acid sequences coding therefor |
PT1471974E (pt) * | 2002-02-06 | 2007-10-12 | Ares Trading Sa | Factor de necrose tumural combinado com interferão em doenças desmielinizantes |
EP3064215A1 (en) * | 2002-10-16 | 2016-09-07 | Samuel F. Hunter | Method for treatment of demyelinating central nervous system disease |
TWI272948B (en) | 2003-05-01 | 2007-02-11 | Ares Trading Sa | HSA-free stabilized interferon liquid formulations |
JP4889505B2 (ja) | 2004-02-02 | 2012-03-07 | アンブレツクス・インコーポレイテツド | 被修飾されたヒト成長ホルモンポリペプチドおよびこれらの使用 |
DE102004008168B4 (de) * | 2004-02-19 | 2015-12-10 | Voxeljet Ag | Verfahren und Vorrichtung zum Auftragen von Fluiden und Verwendung der Vorrichtung |
US7879320B2 (en) * | 2004-05-17 | 2011-02-01 | Ares Trading S.A. | Hydrogel interferon formulations |
UA92146C2 (ru) * | 2004-06-01 | 2010-10-11 | Эйрэс Трейдинг С.А. | Стабилизированная жидкая композиция, которая содержит интерферон |
JP2008500995A (ja) | 2004-06-01 | 2008-01-17 | アレス トレーディング ソシエテ アノニム | タンパク質安定化法 |
TW200633718A (en) * | 2004-12-16 | 2006-10-01 | Applied Research Systems | Treatment of hepatitis c in the asian population |
BG66458B1 (bg) | 2005-03-21 | 2014-10-31 | Иван Иванов | Средство за конкурентно инхибиране на ендогенен гама интерферон |
WO2006119170A2 (en) * | 2005-05-02 | 2006-11-09 | Avigen, Inc. | Use of cytokine-derived peptides in treatment of pain and neurodegenerative disease |
SG155183A1 (en) | 2005-08-26 | 2009-09-30 | Ares Trading Sa | Process for the preparation of glycosylated interferon beta |
KR20080050591A (ko) * | 2005-09-01 | 2008-06-09 | 아레스 트레이딩 에스.에이. | 시신경염 치료 |
JP2009537605A (ja) | 2006-05-24 | 2009-10-29 | メルク セローノ ソシエテ アノニム | 多発性硬化症を治療するためのクラドリビン・レジメン |
DK2234645T3 (da) * | 2007-12-20 | 2012-07-09 | Merck Serono Sa | Peg-interferon-beta-formuleringer |
BG66517B1 (bg) | 2008-04-08 | 2016-02-29 | Tigo Gmbh | Супресор на ендогенния човешки гама - интерферон |
US9359421B2 (en) | 2008-04-08 | 2016-06-07 | Tigo Gmbh | Suppressor of the endogenous interferon-gamma |
US20130017999A1 (en) | 2011-07-14 | 2013-01-17 | Marc Fremont | Methods and Compositions for Evaluating and/or Treating Chronic Immune Diseases |
HUE046944T2 (hu) | 2013-07-18 | 2020-03-30 | Xalud Therapeutics Inc | Készítmény gyulladásos ízületi betegség kezelésére |
BG67190B1 (bg) | 2017-03-29 | 2020-11-16 | Tigo Gmbh | Анти-гама мутантен протеин срещу ендогенния човешки гама интерферон |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6936694B1 (en) * | 1982-05-06 | 2005-08-30 | Intermune, Inc. | Manufacture and expression of large structural genes |
US5075222A (en) * | 1988-05-27 | 1991-12-24 | Synergen, Inc. | Interleukin-1 inhibitors |
EP0502956B1 (en) * | 1989-11-29 | 1997-04-23 | Amgen Boulder Inc. | Production of recombinant human interleukin-1 inhibitor |
WO1991017184A1 (en) * | 1990-04-27 | 1991-11-14 | The Upjohn Company | Modified interleukin-1 inhibitors |
CA2094275C (en) * | 1990-10-17 | 2003-06-03 | Lawrence M. Blatt | Methods and compositions for the treatment of cell proliferation disorders |
US5372808A (en) * | 1990-10-17 | 1994-12-13 | Amgen Inc. | Methods and compositions for the treatment of diseases with consensus interferon while reducing side effect |
US5858355A (en) * | 1990-12-20 | 1999-01-12 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | IRAP gene as treatment for arthritis |
SG89295A1 (en) * | 1991-03-15 | 2002-06-18 | Amgen Inc | Pegylation of polypeptides |
EP0639079B1 (en) * | 1992-04-30 | 2000-01-12 | Amgen Inc. | Methods for treating interleukin-1 and tumor necrosis factor mediated diseases |
EP0661992B1 (en) * | 1992-09-17 | 2004-01-07 | Amgen Inc. | Pharmaceutical formulations of interleukin-1 inhibitors |
US5780021A (en) * | 1993-03-05 | 1998-07-14 | Georgetown University | Method for treating type 1 diabetes using α-interferon and/or β-i |
EP0701563A4 (en) * | 1993-03-08 | 1997-07-02 | Univ Pittsburgh | GENE TRANSFER FOR THE TREATMENT OF CONNECTIVE TISSUES IN A HOST MAMMAL |
EP0689449B1 (fr) * | 1993-03-19 | 2002-10-30 | Vacsyn S.A. | Compositions pour l'application en therapeutique humaine, caracterisees par l'association d'un muramyl-peptide a une cytokine |
US6326353B1 (en) * | 1993-03-23 | 2001-12-04 | Sequus Pharmaceuticals, Inc. | Enhanced circulation effector composition and method |
FR2706772A1 (en) * | 1993-06-22 | 1994-12-30 | Vacsyn Sa | Prevention and treatment of septic syndrome with an immunosuppressant, in particular cyclosporin. |
ES2159630T3 (es) * | 1994-02-08 | 2001-10-16 | Amgen Inc | Sistema de administracion por via oral de proteinas g-csf quimicamente modificadas. |
-
1997
- 1997-08-15 US US08/911,893 patent/US6013253A/en not_active Expired - Lifetime
-
1998
- 1998-07-15 CN CNB988081520A patent/CN1183963C/zh not_active Expired - Fee Related
- 1998-07-15 IL IL13434598A patent/IL134345A0/xx active IP Right Grant
- 1998-07-15 DE DE69835823T patent/DE69835823T2/de not_active Expired - Lifetime
- 1998-07-15 PT PT98933344T patent/PT1003546E/pt unknown
- 1998-07-15 AT AT98933344T patent/ATE338563T1/de active
- 1998-07-15 CA CA002299361A patent/CA2299361C/en not_active Expired - Fee Related
- 1998-07-15 DK DK98933344T patent/DK1003546T3/da active
- 1998-07-15 EP EP98933344A patent/EP1003546B1/en not_active Expired - Lifetime
- 1998-07-15 JP JP2000509439A patent/JP3813440B2/ja not_active Expired - Lifetime
- 1998-07-15 HU HU0002755A patent/HU229045B1/hu unknown
- 1998-07-15 KR KR10-2000-7001097A patent/KR100415636B1/ko not_active IP Right Cessation
- 1998-07-15 AU AU83006/98A patent/AU741074B2/en not_active Expired
- 1998-07-15 ES ES98933344T patent/ES2267188T3/es not_active Expired - Lifetime
- 1998-07-15 WO PCT/US1998/014622 patent/WO1999008702A1/en active IP Right Grant
- 1998-07-29 TW TW087112465A patent/TW474817B/zh not_active IP Right Cessation
-
2000
- 2000-02-02 IL IL134345A patent/IL134345A/en not_active IP Right Cessation
-
2001
- 2001-02-16 HK HK01101141A patent/HK1030157A1/xx not_active IP Right Cessation
-
2006
- 2006-11-27 CY CY20061101704T patent/CY1107314T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
EP1003546B1 (en) | 2006-09-06 |
CN1183963C (zh) | 2005-01-12 |
CA2299361A1 (en) | 1999-02-25 |
CY1107314T1 (el) | 2012-11-21 |
KR100415636B1 (ko) | 2004-01-24 |
CN1267225A (zh) | 2000-09-20 |
CA2299361C (en) | 2009-09-29 |
TW474817B (en) | 2002-02-01 |
PT1003546E (pt) | 2006-12-29 |
DE69835823D1 (de) | 2006-10-19 |
JP3813440B2 (ja) | 2006-08-23 |
HUP0002755A3 (en) | 2001-11-28 |
KR20010030563A (ko) | 2001-04-16 |
EP1003546A1 (en) | 2000-05-31 |
AU8300698A (en) | 1999-03-08 |
HU229045B1 (en) | 2013-07-29 |
IL134345A (en) | 2011-03-31 |
HUP0002755A2 (hu) | 2000-12-28 |
AU741074B2 (en) | 2001-11-22 |
US6013253A (en) | 2000-01-11 |
DE69835823T2 (de) | 2007-08-09 |
WO1999008702A1 (en) | 1999-02-25 |
DK1003546T3 (da) | 2006-10-30 |
ATE338563T1 (de) | 2006-09-15 |
IL134345A0 (en) | 2001-04-30 |
JP2001515047A (ja) | 2001-09-18 |
ES2267188T3 (es) | 2007-03-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1030157A1 (en) | Use of consensus interferon and compositions comprising consensus interferon. | |
GR3032207T3 (en) | 2-Bromomelatonin in the therapy of sleep disorders | |
TW265265B (da) | ||
HK1084862A1 (en) | Use of omega interferon in the manufacturing of a medicament for treating viral disease in a warm-blooded animal subject | |
EP1674107B8 (en) | Use of daptomycin | |
BR9911076A (pt) | Uso de peg-ifn-alfa e ribavirina para o tratamento de hepatite c crÈnica | |
IL123889A0 (en) | Pharmaceutical angiostatic dipeptide compositions and methods of use thereof | |
IL138665A0 (en) | Peptide factor | |
BR9807076B1 (pt) | "uso de acetato de glatirâmero para a fabricação de medicamento para o tratamento de esclerose múltipla e composição farmacêutica" | |
MY118526A (en) | Method for improving the pharmacokinetics of tipranavir | |
ES2160643T3 (es) | Composiciones que contienen g-csf y proteina de union al tnf. | |
IL130785A0 (en) | Use of an anti-cd40l compound in the manufacture of a medicament for treating a patient with an autoimmune disease or chronic immune system disorder and pharmaceutical compositions containing the same | |
HK1026843A1 (en) | Somatostatin and somatostatin agonists for treating insulin insensitivity and syndrome x. | |
YU45103A (sh) | Upotreba sarp/1 za lečenje i prevenciju skleroderme | |
IL145722A0 (en) | Pharmaceutical composition comprising growth hormone and interferon | |
HK1015692A1 (en) | Ctla-8 in combination with g-csf or with g-csf and il-6, and use of ctla-8, for treating infections | |
EP1048294A3 (en) | Use of a nitrate vasodilator alone or in combination with capsaicin for the treatment of pain | |
WO1999013894A3 (en) | Use of ifn-alpha and amantadine for the treatment of chronic hepatitis c | |
MY119359A (en) | Use of consensus interferon for reducing the side effects of interferon treatment in viral hepatitis. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PE | Patent expired |
Effective date: 20180714 |